Essential CNS drug development
Our rough guess is there are 51,750 words in this book.
At a pace averaging 250 words per minute, this book will take 3 hours and 27 minutes to read. With a half hour per day, this will take 7 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
We earn a commission on purchases
Author
Publication
2012 - Cambridge University Press, Cambridge, England
Language
English
Word Count
51,750 words, Guess
Page Count
207 pages
Identifiers
- Open LibraryOL25102226M
- ISBN-139780521766067
- OCLC Control Number760270762
- Library of Congress Control Number2011046215
Classifications
- DDC615.1/9
- LCCRM301.25 .E82 2012
Description
"Central Nervous System disorders have an enormous impact on individuals and on society as a whole. The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities. Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily. Written and edited by experts from different sectors actively engaged in CNS drug development, this is a unique resource for drug developers, investigators, academics and clinicians"--Provided by publisher.
Subjects
Topics
Other Editions
- Essential CNS drug development
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!